Diasorin

Headquartered in Italy and listed on the Italian Stock Exchange within the FTSE MIB Index, Diasorin is a global leader in the In Vitro Diagnostic (IVD) field and, since 2021, has been active in the Life Science business.

For over 50 years, the Company has been developing, producing, and marketing reagent kits used by diagnostic laboratories worldwide. The Group operates across five continents through 35 companies, 4 branches, 10 manufacturing facilities, and 9 research and development centers.

Our extensive diagnostic testing and life science offering, continuously enhanced through significant investments in research, positions Diasorin as the player with the broadest range of specialty tests available in the diagnostic market, identifying the Group as “The Diagnostic Specialist.” With a team of over 3,200 employees worldwide, including more than 400 researchers, we are committed to improving healthcare and enhancing people's quality of life.

We value diversity, skills, and talent as key drivers of innovation and excellence, fostering an inclusive work environment that evolves alongside the ever-changing landscape of global healthcare.